Nasdaq Markets

Image source: The Motley Fool.

In this week's Rule Breaker Investing podcast, we revisit David Gardner's five-stock samplers from 2017 and 2018 and find out how they fared compared with the market. Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), Amazon.com (NASDAQ: AMZN), and Apple (NASDAQ: AAPL) were top perfo

(RTTNews) - Vicor Corp. (VICR) reported that its net income for the fourth quarter declined to $1.3 million or $0.03 per share, from $6.9 million or $0.17 per share in the prior year. Revenues for the fourth quarter were $63.1 million, a 14.4% decrease from $73.7 million last

A new study released this month in the International Journal of Epidemiology has found that women who drink milk every day may be at an elevated risk of developing breast cancer. The observational study followed 52,795 women in North America over a period of 7.9 years, and one

Image source: The Motley Fool.

Image source: The Motley Fool.

(RTTNews) - The Japanese stock market is extending losses on Wednesday from the previous session, while the safe-haven yen strengthened following the weak cues overnight from Wall Street amid continued fears that the coronavirus outbreak could escalate into a pandemic. The U.S.

(RTTNews) - Infinera Corp. (INFN) reported that its GAAP net loss for the fourth quarter narrowed to $66.6 million or $0.37 per share, from $133.5 million or $0.76 per share in the fourth quarter of 2018.

Image source: The Motley Fool.

Image source: The Motley Fool.

Image source: The Motley Fool.

(RTTNews) - The Australian stock market is notably lower on Wednesday with stocks lower across the board, extending recent losses following the weak cues overnight from Wall Street amid continued fears that the coronavirus outbreak could escalate into a pandemic.

Tandem Diabetes Care (NASDAQ: TNDM) followed the broader market and traded down on Tuesday, despite reporting quarterly results that featured an unexpected bottom-line profit.

Amazon (NASDAQ: AMZN) is reportedly taking steps to get its hands on inventory as the COVID-19 coronavirus outbreak continues to spread, and worries about it becoming a pandemic rise.

GW Pharmaceuticals (NASDAQ: GWPH) announced its fourth quarter and full year financial results Tuesday afternoon. Although the company ended up missing the earnings target set by Wall Street, GW Pharma did manage to handily beat analysts' revenue expectations for the company.

Regional Management (RM) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $0.90 per share a year ago. These figures are adjusted for non-recurring items.

Caesars Entertainment (CZR) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.

Veracyte (VCYT) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items.

WW International (WW) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.63 per share a year ago. These figures are adjusted for non-recurring items.

Red Robin (RRGB) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for non-recurring items.